Hyperfine Unveils World’s First Portable MR Brain Imaging System for Acute Brain Injury

Hyperfine introduces the world's pioneering FDA-cleared, portable magnetic resonance brain imaging system, utilising ultra-low-field technology. Its primary focus is the early detection of acute brain injury in ECMO patients.

The Swoop® system is a portable device utilising magnetic resonance imaging to generate head images showcasing internal structures. These images, when assessed by a qualified physician, offer valuable insights that can aid in making diagnostic assessments when a comprehensive examination isn't feasible clinically.

The Swoop® system extends the benefits of MR brain imaging to patients who are too unstable to be moved, ensuring they receive this crucial diagnostic tool.

This data underscores another vital application of the Swoop® system, emphasising how timely access to MR brain imaging can significantly reduce care delays and make a profound impact on patient treatment and clinical decision-making.

Patients on ECMO often can't be moved to traditional high-field MRI suites because of their unstable condition. The study assessed the viability of employing portable MR brain imaging to monitor ECMO patients, showcasing its potential benefit in offering early detection of ischaemic stroke compared to CT scans.

The preliminary results of this research highlight the viability of employing portable MR brain imaging in adult ECMO patients. They suggest a notable prevalence of acute brain injury, primarily characterised by ischaemic stroke. The study emphasises the significance of MR-based neuroimaging in detecting ABI (Acute Brain Injury) and its potential to enhance neurological outcomes.

The Swoop® system has gained approval for brain imaging in multiple countries, such as Canada and Australia.